Zur Kurzanzeige

Immunopathogenesis of cortical demyelination in Multiple Sclerosis

dc.contributor.advisorNessler, Stefan Dr.
dc.contributor.authorLagumersindez Denis, Nielsen
dc.date.accessioned2015-11-20T13:14:49Z
dc.date.available2016-11-09T23:50:04Z
dc.date.issued2015-11-20
dc.identifier.urihttp://hdl.handle.net/11858/00-1735-0000-0028-8638-F
dc.identifier.urihttp://dx.doi.org/10.53846/goediss-5375
dc.language.isoengde
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.ddc610
dc.titleImmunopathogenesis of cortical demyelination in Multiple Sclerosisde
dc.typedoctoralThesisde
dc.contributor.refereeBrück, Wolfgang Prof. Dr.
dc.date.examination2015-11-09
dc.description.abstractengCortical demyelination is a key pathological feature of multiple sclerosis (MS) and clinically linked to cognitive deficits and disability progression. Extensive band-like subpial demyelination is even a specific feature of the disease. However, the immunological mechanisms driving cortical demyelination have not yet been defined due to a lack of cortical pathology in the classical experimental models of MS. To elucidate the immunopathogenesis of cortical demyelination, we developed a novel mouse model with subpial and perivascular cortical MS-like lesions. We demonstrate that in addition to a pathogenic anti-myelin antibody response, perivascular cortical demyelination is primarily dependent on activated encephalitogenic T cells, natural killer (NK) cells and CCR2+ inflammatory monocytes. In contrast, subpial cortical demyelination occurs independently of activated T cells, but requires specific antibodies and a fully functional complement cascade. To translate the results obtained into a treatment option for MS, we evaluated the therapeutic efficacy of a humanized mouse anti-human CCR2 antibody, which efficiently depletes CCR2+ monocytes in marmosets with experimental autoimmune encephalomyelitis (EAE). Depleting inflammatory monocytes was well tolerated and significantly reduced cortical demyelination in marmoset monkeys with EAE. Our findings thus delineate a differential involvement of immunological effector mechanisms in perivascular and subpial cortical lesion formation, shed light on the exquisite vulnerability of subpial cortical tissue in multiple sclerosis and translate into a preclinical treatment approach for cortical demyelination.de
dc.contributor.coRefereeReichardt, Holger Prof. Dr.
dc.subject.engcortical demyelinationde
dc.subject.engmultiple sclerosisde
dc.subject.engEAEde
dc.subject.engstereotactic injectionde
dc.subject.engtransgenic mouse modelde
dc.subject.engmarmosetde
dc.identifier.urnurn:nbn:de:gbv:7-11858/00-1735-0000-0028-8638-F-3
dc.affiliation.instituteMedizinische Fakultät
dc.subject.gokfullMedizin (PPN619874732)de
dc.description.embargoed2016-11-09
dc.identifier.ppn84048691X


Dateien

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige